NCT03452774 - SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry | Biotech Hunter

Enrollment

50,000

Participants

Timeline

Start Date

January 1, 2018

Primary Completion Date

December 31, 2038

Study Completion Date

June 30, 2040

Conditions

Cancer, MetastaticCancerCancer of PancreasCancer of LiverCancer of StomachCancer LiverCancer of RectumCancer of KidneyCancer of EsophagusCancer of CervixCancer of ColonCancer of LarynxCancer, LungCancer, BreastCancer, AdvancedCancer ProstateCancer of NeckCancer of SkinNeuroendocrine TumorsCarcinomaMismatch Repair DeficiencyBRCA Gene RearrangementNon Hodgkin LymphomaLeukemiaNon Small Cell Lung CancerCholangiocarcinomaGlioblastomaCentral Nervous System TumorMelanomaUrothelial CarcinomaBladder CancerOvarian CancerEndometrial CancerTesticular CancerBreast CancerCOVIDMyelofibrosisMyeloproliferative NeoplasmMyeloproliferative DisordersFollicular LymphomaMantle Cell LymphomaMarginal Zone LymphomaMyelodysplastic Syndromes

Interventions

OTHER

Clinical Trial Matching

Using a proprietary application programming interface (API) linked to existing electronic health records (EHR) platforms, individual clinical data is extracted, analyzed and matched to a parametric database of existing institutional and non-institutional CT. Machine learning algorithms allow for dynamic matching based on CT allocation and availability for optimized matching.

Trial Locations (4)

10006

RECRUITING

Massive Bio, Inc, New York

33487

RECRUITING

Massive Bio SYNERGY-AI site, Boca Raton

77030

RECRUITING

Massive Bio SYNERGY-AI site, Houston

94143

RECRUITING

Massive Bio SYNERGY-AI site, San Francisco